IP Rules for Synthetic Bio Generate More Questions Than Answers

by jeeg 13. May 2011 23:05
The biotechnology world was rocked a year ago this month, when J. Craig Venter, Ph.D., reported that he led a team of 17 researchers at his namesake institute in completing the second of three key steps toward creating a fully synthetic organism. The team created the largest man-made DNA struc... [More]

Patent Application Involving Improperly Obtained Genetic Samples Abandoned

by jeeg 11. April 2011 19:18
The Network of the Indigenous Peoples-Solomons (NIPS) welcomes the abandonment of a US patent application that uses genetic samples from Solomon Islanders, in a case that raises major ethical questions.   According to the USPTO’s Patent Application Information Retrieval system, U... [More]

Myriad Offers to "Gift" Its Breast Cancer Patent to Australia

by jeeg 30. September 2010 00:00
Myriad Genetics, in mid-August, 2010, sent a letter offering to surrender its Australian BRCA1 breast cancer gene.  The letter said, "Myriad wishes to gift Australian Patent No 686004 (the Patent) to the people of Australia."  On September 2, 2010, the Commissioner of Patents published n... [More]

CRG Issues Report on Gene Patents

by jeeg 6. August 2010 01:26
The Council for Responsible Genetics has issued a new report exploring the cost and scope of gene patents in the U.S. Basic research into human genetics and genomics has revealed some useful discoveries about the link between genes and human health and disease.  These discoverie... [More]

Bid to halt patenting of genes in Australia

by jeeg 8. June 2010 00:02
A landmark court case is set to challenge the legality of an Australian-issued patent for a breast and ovarian cancer gene. If successful, the case could set a precedent leading to other gene patents being overturned. The case could also strengthen calls by researchers, doctors and heal... [More]
Log in